- Home
- SLGL vs CLPR Comparison
SLGL vs CLPR Comparison
Compare SLGL & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- CLPR
- Stock Information
- Founded
- SLGL 1997
- CLPR 2015
- Country
- SLGL Israel
- CLPR United States
- Employees
- SLGL N/A
- CLPR N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- SLGL Health Care
- CLPR Real Estate
- Exchange
- SLGL Nasdaq
- CLPR Nasdaq
- Market Cap
- SLGL 49.4M
- CLPR 57.5M
- IPO Year
- SLGL 2018
- CLPR 2017
- Fundamental
- Price
- SLGL $23.48
- CLPR $4.41
- Analyst Decision
- SLGL Buy
- CLPR
- Analyst Count
- SLGL 1
- CLPR 0
- Target Price
- SLGL $40.00
- CLPR N/A
- AVG Volume (30 Days)
- SLGL 30.1K
- CLPR 107.6K
- Earning Date
- SLGL 08-15-2025
- CLPR 08-07-2025
- Dividend Yield
- SLGL N/A
- CLPR 8.63%
- EPS Growth
- SLGL N/A
- CLPR N/A
- EPS
- SLGL N/A
- CLPR N/A
- Revenue
- SLGL $23,931,000.00
- CLPR $154,103,000.00
- Revenue This Year
- SLGL N/A
- CLPR N/A
- Revenue Next Year
- SLGL $31.17
- CLPR N/A
- P/E Ratio
- SLGL N/A
- CLPR N/A
- Revenue Growth
- SLGL 264.86
- CLPR 7.69
- 52 Week Low
- SLGL $4.01
- CLPR $3.39
- 52 Week High
- SLGL $26.89
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- SLGL 72.14
- CLPR 67.54
- Support Level
- SLGL $20.06
- CLPR $3.90
- Resistance Level
- SLGL $26.89
- CLPR $4.49
- Average True Range (ATR)
- SLGL 2.57
- CLPR 0.24
- MACD
- SLGL 0.63
- CLPR 0.06
- Stochastic Oscillator
- SLGL 75.10
- CLPR 91.41
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.